CNS Pharmaceuticals, Inc. (NASDAQ: CNSP), Moving the Needle in GBM and Brain Cancer Research
When CNS went public in 2019, the funds went primarily into pre-clinical preparation, trial design approval, and drug manufacturing for…
When CNS went public in 2019, the funds went primarily into pre-clinical preparation, trial design approval, and drug manufacturing for…
Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, is continuing to accumulate international patents; most recently the company…
FingerMotion (NASDAQ: FNGR) recently launched its mobile device protection product, looking to tap into an industry valued at approximately $10.6…
Correlate Infrastructure Partners (OTCQB: CIPI) is empowering real estate investment trusts (“REITs”), investors, and commercial property owners to profitably implement…
Cybin (NYSE American: CYBN) (NEO: CYBN) is a biotechnology company focused on progressing Psychedelics to Therapeutics(TM). The company today announced…
FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), a Canadian-based, growth-stage company committed to providing commercially viable and sustainable, cradle-to-cradle, clean-energy solutions, has…
REZYFi Lending sees higher margin lending opportunities as well as significant market opportunity to provide the growing and underserved cannabis…
Cepton Technologies (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, has received a nonbinding letter of intent…
A new study shows promise in treating alcohol addiction with psychedelic mushroom compound, psilocybin These results align with efforts and…
Plant-based foods investment company Eat Well Investment Group Inc. is an innovative producer of food products designed to help nations…